Micheál Mac Aogáin
Trinity College, Dublin
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Micheál Mac Aogáin.
PLOS Pathogens | 2015
Aisling F. Brown; Alison G. Murphy; Stephen J. Lalor; John M. Leech; Kate M. O’Keeffe; Micheál Mac Aogáin; Dara P. O’Halloran; Keenan A. Lacey; Mehri Tavakol; Claire H. Hearnden; Deirdre Fitzgerald-Hughes; Hilary Humphreys; Jerome Fennell; Willem J. B. van Wamel; Timothy J. Foster; Joan A. Geoghegan; Ed C. Lavelle; Thomas R. Rogers; Rachel M. McLoughlin
Mechanisms of protective immunity to Staphylococcus aureus infection in humans remain elusive. While the importance of cellular immunity has been shown in mice, T cell responses in humans have not been characterised. Using a murine model of recurrent S. aureus peritonitis, we demonstrated that prior exposure to S. aureus enhanced IFNγ responses upon subsequent infection, while adoptive transfer of S. aureus antigen-specific Th1 cells was protective in naïve mice. Translating these findings, we found that S. aureus antigen-specific Th1 cells were also significantly expanded during human S. aureus bloodstream infection (BSI). These Th1 cells were CD45RO+, indicative of a memory phenotype. Thus, exposure to S. aureus induces memory Th1 cells in mice and humans, identifying Th1 cells as potential S. aureus vaccine targets. Consequently, we developed a model vaccine comprising staphylococcal clumping factor A, which we demonstrate to be an effective human T cell antigen, combined with the Th1-driving adjuvant CpG. This novel Th1-inducing vaccine conferred significant protection during S. aureus infection in mice. This study notably advances our understanding of S. aureus cellular immunity, and demonstrates for the first time that a correlate of S. aureus protective immunity identified in mice may be relevant in humans.
Journal of Antimicrobial Chemotherapy | 2015
Yvonne Lynagh; Micheál Mac Aogáin; Anne Walsh; Thomas R. Rogers; Magnus Unemo; Brendan Crowley
Detailed characterization of the first high-level azithromycin-resistant Neisseria gonorrhoeae cases in Ireland
Genome Announcements | 2015
Micheál Mac Aogáin; Emma Roycroft; Philomena Raftery; Simone Mok; Margaret Fitzgibbon; Thomas R. Rogers
ABSTRACT Mycobacterium chimaera is an opportunistic human pathogen implicated in both pulmonary and cardiovascular infections. Here, we report the draft genome sequences of three strains isolated from human respiratory specimens.
Journal of Clinical Microbiology | 2016
Peter M. Kinnevey; Anna C. Shore; Micheál Mac Aogáin; E. Creamer; Gráinne I. Brennan; Hilary Humphreys; Thomas R. Rogers; Brian O'Connell; David C. Coleman
ABSTRACT Whole-genome sequencing (WGS) of 41 patient and environmental sequence type 22 methicillin-resistant Staphylococcus aureus staphylococcal cassette chromosome mec type IV (ST22-MRSA-IV) isolates recovered over 6 weeks in one acute hospital ward in Dublin, Ireland, where ST22-MRSA IV is endemic, revealed 228 pairwise combinations differing by <40 single nucleotide variants corresponding to potential cross-transmission events (CTEs). In contrast, 15 pairwise combinations of isolates representing five CTEs were previously identified by conventional molecular epidemiological typing. WGS enhanced ST22-MRSA-IV tracking and highlighted potential transmission of MRSA via the hospital environment.
Journal of global antimicrobial resistance | 2015
Micheál Mac Aogáin; Shauna Kilkenny; Claire Walsh; Sinéad Lindsay; Geraldine Moloney; T E Morris; Sophie Jones; Thomas R. Rogers
The aim of this study was to determine whether alternative resistance mechanisms, other than mutation in the quinolone resistance-determining region (QRDR) of DNA gyrase, could confer fluoroquinolone resistance in Clostridium difficile. An in vitro-generated C. difficile mutant exhibiting increased fluoroquinolone resistance was isolated through antibiotic selection on ciprofloxacin. The QRDR of this mutant was investigated by chain-termination sequencing and was found to be devoid of mutation. To determine the nature of the non-QRDR resistance mechanism in this strain, the genomes of the mutant and wild-type strains were sequenced. The gyrBA region from a collection of clinical isolates exhibiting variable fluoroquinolone resistance levels was also sequenced and was compared with that present in 918 publicly available C. difficile genomic data sets. Whole-genome sequence analysis of the fluoroquinolone-resistant mutant revealed a single non-synonymous substitution (Ala384Asp) at the predicted primary dimer interface of GyrA, far beyond the classically defined QRDR. This novel mutation caused increased resistance to ciprofloxacin, ofloxacin, levofloxacin and moxifloxacin while conferring hypersusceptibility to novobiocin. Several novel extra-QRDR polymorphisms in C. difficile DNA gyrase were identified among clinical isolates, whilst observed fluoroquinolone resistance in strains devoid of gyrBA mutations confirmed the existence of DNA gyrase-independent resistance mechanisms in this species. In conclusion, we report the first non-QRDR mutation to confer fluoroquinolone resistance in C. difficile. Although the Ala384Asp substitution was not detected in clinical isolates, this study revealed a diversity of alternative extra-QRDR polymorphisms in DNA gyrase whose association with fluoroquinolone resistance warrants further investigation.
Genome Announcements | 2014
Micheál Mac Aogáin; Bushra M. Johari; James E. Bower; Rf O'Toole
ABSTRACT Multidrug resistance constitutes a threat worldwide to the management of tuberculosis (TB). We report the draft whole-genome sequence of a lineage 3 (East-African Indian) isolate of Mycobacterium tuberculosis which presented as multidrug resistant in New Zealand, and describe a number of single-nucleotide polymorphisms in genes relating to drug resistance.
Genome Announcements | 2017
Micheál Mac Aogáin; Nicholas Fennelly; Anne Walsh; Yvonne Lynagh; Michaël Bekaert; Brendan Lawlor; Paul Walsh; B. Kelly; Thomas R. Rogers; Brendan Crowley
ABSTRACT Here, we report the draft genome assemblies of 14 azithromycin-resistant Neisseria gonorrhoeae clinical isolates, representing the first such strains identified in Ireland. Among these isolates are the first reported highly resistant strains (MIC >256 mg/liter), which both belonged to the ST1580 sequence type.
Irish Veterinary Journal | 2015
Máire McElroy; Martin Hill; Geraldine Moloney; Micheál Mac Aogáin; Shane McGettrick; Áine O’Doherty; Thomas R. Rogers
BackgroundClostridium difficile is a recognised cause of typhlocolitis and diarrhoea in neonatal pigs but has never been confirmed in association with pathology and disease in Irish pigs.Case PresentationFour neonatal piglets, with a history of diarrhoea were referred to the Central Veterinary Research Laboratory, Backweston for necropsy. They were from a fully integrated, commercial pig farm with approximately 1000 sows. Three piglets had acute, superficial, erosive and suppurative typhlocolitis and the other had mild suppurative mesocolitis. Clostridium difficile (C. difficile) toxins A/B were detected using ELISA in the colonic contents from each piglet. C. difficile isolates from two of the piglets were PCR-ribotyped as 078 and an isolate from a third pig was ribotyped as 110.ConclusionsThis is the first report confirming C. difficile in association with typhlocolitis in Irish pigs.
Genome Announcements | 2016
Micheál Mac Aogáin; Sanjay S. Gautam; James E. Bower; Indira Basu; Rf O'Toole
ABSTRACT The Rangipo genotype of the Mycobacterium tuberculosis complex has been associated with a number of tuberculosis (TB) outbreaks in New Zealand. We report here the draft whole-genome sequence of a representative isolate of this strain.
Genome Announcements | 2015
Micheál Mac Aogáin; James E. Bower; Indira Basu; Joshua T. Freeman; Ronan F. O’Toole
ABSTRACT We report here the draft whole-genome sequence of a drug-susceptible lineage 3 (East-African Indian) isolate of Mycobacterium tuberculosis from New Zealand (NZ3DS1) and compare it to a multidrug-resistant lineage 3 isolate (NZ3MDR1) with an identical 24-locus mycobacterial interspersed repetitive-unit–variable-number tandem-repeat profile.